Ad
related to: MG Management Inc
Search results
Brokerages Set Magna International Inc. (NYSE:MGA) PT at $60.00
ETF DAILY NEWS· 6 days agoMagna International Inc. (NYSE:MGA – Get Free Report) (TSE:MG) has earned an average rating of “Hold” from the sixteen ratings firms that are currently ...
Innovent to Present Multiple Clinical Study Results of Mazdutide at the ADA's 84th Scientific...
Morningstar· 1 day agoInnovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the ...
AlphaWave L-Theanine adds the ideal state of relaxed wakefulness to stress-management beverages
Food Navigator USA· 10 hours agoAlphaWave L-Theanine, a leading clinically studied supplement ingredient for stress-relief has ideal qualities for liquid and powdered beverage use.
Small Business - Picayune Item | Picayune Item
The Picayune Item· 3 days agoTOKYO and CAMBRIDGE, Mass., June 09, 2024 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters ...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 5 days agoThe study met its primary endpoint of ≥1-stage improvement in fibrosis with no worsening of MASH after 24 weeks of treatment for both the 50 mg EFX (41%, p<0.05) and 28 < ...
Gannex Announces Poster Presentation of Positive Interim 12-Week Results from Phase II Clinical...
KOLR - KSFX Ozarks· 2 days ago("Gannex"), a wholly-owned company of Ascletis Pharma Inc. (HKEX:1672, "Ascletis") dedicated to the research and development and commercialization of new drugs in the field ...
Health Care Week In Review: House Held Oversight Hearing on the 340B Program and HHS Expanded...
JD Supra· 3 days agoBelow is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance;...
Ruvidar(TM) Enhances Efficacy of Cancer Drug
Digital Journal· 3 days agoTORONTO, ON / ACCESSWIRE / June 10, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated ...
